BlackRock Fund Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

BlackRock Fund Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$152K	Buy	1,640 +17	+1%	+$1.62K	﹤0.01%	3495
2016 Q3	$167K	Buy	1,623 +130	+9%	+$14.6K	﹤0.01%	3504
2016 Q2	$177K	Buy	1,493 +1,410	+1,699%	+$141K	﹤0.01%	3500
2016 Q1	$6K	Buy	83 +16	+24%	+$1.06K	﹤0.01%	4067
2015 Q4	$5K	Buy	+67	New	+$5.13K	﹤0.01%	4140

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

TFCP

Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SIM

Sigma Investment Management Portland, Oregon $125M AUM 4.75% 1-Year Est. Return

BlackRock Fund Advisors's VBIV Position: Q4 2016 in Review

BlackRock Fund Advisors increased its VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) stake by 1% in Q4 2016, buying an estimated $1.62K and bringing the position to 1,640 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #3495.

BlackRock Fund Advisors first reported a position in VBIV in Q4 2015 and has held it in 5 quarters since. The position peaked at $177K in Q2 2016. 21 funds tracked by Wall St. Rank hold VBIV as of Q4 2016.

BlackRock Fund Advisors held 1,640 shares of VBI Vaccines, Inc. New Common Stock (Canada) worth $152K as of Q4 2016.
BlackRock Fund Advisors bought 17 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2016, an estimated $1.62K.
VBI Vaccines, Inc. New Common Stock (Canada) made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3495 holding.
BlackRock Fund Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2015 and has held it in 5 quarters since.
BlackRock Fund Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $177K in Q2 2016.
21 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.